Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 2, 2004, Pages 189-196

  Emanuele, Enzo ^a   Peros, Emmanouil ^a   Tomaino, Carmine ^b   Feudatari, Enrica ^c   Bernardi, Livia ^b   Binetti, Giuliano ^c   Maletta, Raffaele ^b   Micieli, Giuseppe ^a   Bruni, Amalia C ^b   Geroldi, Diego ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Regional Center of Neurogenetics   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Apolipoprotein(a); Lipoprotein(a); Post stroke dementia

Indexed keywords

APOLIPOPROTEIN A; ISOPROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MULTIINFARCT DEMENTIA; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS A; CEREBRAL INFARCTION; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; HUMANS; INTRACRANIAL EMBOLISM; ITALY; LIPOPROTEIN(A); MALE; MOLECULAR WEIGHT; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; REFERENCE VALUES; RISK FACTORS;

EID: 4344652762     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079200     Document Type: Article

References (48)

1. Grieve R, Hutton J, Bhalla A, Rastenyte D, Ryglewicz D, Sarti C, Lamassa M, Giroud M, Dundas R, Wolfe CD: A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke 2001;32:1684-1691.
2. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
3. Roman GC: Vascular dementia: Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003;51:S296-S304.
4. McCarron MO, Delong D, Alberts MJ: APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis. Neurology 1999;53:1308-1311.
5. Saunders AM: Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses. J Neuropathol Exp Neurol 2000;59:751-758.
6. de la Torre JC: Alzheimer's disease: How does it start? J Alzheimers Dis 2002;4:497-512.
7. Banati RB, Gehrmann J, Wiessner C, Hossmann KA, Kreutzberg GW: Glial expression of the beta-amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab 1995;15:647-654.
8. Kim HS, Lee SH, Kim SS, Kim YK, Jeong SJ, Ma J, Han DH, Cho BK, Suh YH: Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex. Neuroreport 1998;9:533-537.
9. Sutton ET, Hellermann GR, Thomas T: Beta-amyloid-induced endothelial necrosis and inhibition of nitric oxide production. Exp Cell Res 1997;230:368-376.
10. Marcovina SM, Koschinsky ML: Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol 2003;14:361-366.
11. Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P: Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med 2000;132:533-537.
12. Angles-Cano E, Rojas G: Apolipoprotein(a): Structure-function relationship at the lysinebinding site and plasminogen activator cleavage site. Biol Chem 2002;383:93-99.
13. Angles-Cano E, de la Pena Diaz A, Loyau S: Inhibition of fibrinolysis by lipoprotein(a). Ann NY Acad Sci 2001;936:261-275.
14. de la Pena-Diaz A, Izaguirre-Avila R, Angles-Cano E: Lipoprotein Lp(a) and atherothrombotic disease. Arch Med Res 2000;31:353-359.
15. Misirli H, Somay G, Ozbal N, Yasar Erenoglu N: Relation of lipid and lipoprotein(a) to ischaemic stroke. J Clin Neurosci 2002;9:127-132.
16. Peng DQ, Zhao SP, Wang JL: Lipoprotein(a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk 1999;6:1-6.
17. Glader CA, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, Dahlen GH: Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested casecontrol study in Northern Sweden. Stroke 1999;30:2013-2018.
18. DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI: Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet 1995;56:287-293.
19. Dahlen G: Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111-126.
20. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H: Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996;37:2569-2585.
21. Marz W, Beckmann A, Scharnagl H, Siekmeier R, Mondorf U, Held I, Schneider W, Preissner KT, Curtiss LK, Gross W, Huttinger M: Heterogeneous lipoprotein(a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. FEBS Lett 1993;325:271-275.
22. Kolsch H, Ptok U, Mohamed I, Schmitz S, Rao ML, Maier W, Heun R: Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am J Med Genet 2003;121B:128-130.
23. Kang C, Dominguez M, Loyau S, Miyata T, Durlach V, Angles-Cano E: Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: A study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody. Arterioscler Thromb Vasc Biol 2002;22:1232-1328.
24. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: A case-control study. Lancet 2001;10:436-439.
25. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP: Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002;33:2351-2356.
26. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stad EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
28. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
29. Peynet J, Beaudeux JL, Woimant F, Flourie F, Giraudeaux V, Vicaut E, Launay JM: Apolipoprotein(a) size polymorphism in young adults with ischemic stroke. Atherosclerosis. 1999;142:233-239.
30. Elisaf M, Kitsos G, Bairaktari E, Kalaitzidis R, Kalogeropoulos C, Psilas K: Metabolic abnormalities in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 2001;79:129-132.
31. Geroldi D, Bellotti V, Buscaglia P, Bonetti G, Gazzaruso C, Caprioli A, Fratino P: Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample. Clin Chim Acta 1993;22:159-169.
32. Gazzaruso C, Garzaniti A, Falcone C, Geroldi D, Finardi G, Fratino P: Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in type 2 diabetic patients and in non-diabetic subjects. Diabet Med 2001;18:589-594.
33. Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A: Lipoprotein(a) and genetic polymorphisms of clotting factor V, prothrombin, and methylene-tetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-3682.
34. Rader DJ, Hoeg JM, Brewer HB Jr: Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 1994;120:1012-1025.
35. Wahn F, Daniel V, Kronenberg F, Opelz G, Michalk DV, Querfeld U: Impact of apolipoprotein(a) phenotypes on long-term renal transplant survival. J Am Soc Nephrol 2001;12:1052-1058.
36. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P: Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. Diabetes Care 2002;25:1418-1424.
37. Solfrizzi V, Panza F, D'Introno A, Colacicco AM, Capurso C, Basile AM, Capurso A: Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:732-736.
38. Pati U, Pati N: Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism. Mol Genet Metab 2000;71:87-92.
39. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 1997;277:813-817.
40. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, Hauw JJ: Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 2002;103:481-487.
41. Haring HP: Cognitive impairment after stroke. Curr Opin Neurol 2002;15:79-84.
42. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T: Post-stroke dementia: Clinical features and risk factors. Stroke 2000;31:1494-1501.
43. Urakami K, Wada-Isoe K, Wakutani Y, Ikeda K, Ji Y, Yamagata K, Kowa H, Okada A, Adachi Y, Nakashima K: Lipoprotein(a) phenotypes in patients with vascular dementia. Dement Geriatr Cogn Disord 2000;11:135-138.
44. Urakami K, Mura T, Takahashi K: Lp(a) lipoprotein in cerebrovascular disease and dementia. Jpn J Psychiatry Neurol 1987;41:743-748.
45. Jurgens G, Koltringer P: Lipoprotein(a) in ischemic cerebrovascular disease: A new approach to the assessment of risk for stroke. Neurology 1987;37:513-515.
46. Lindgren A, Nilsson-Ehle P, Norrving B, Johansson BB: Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurol Scand 1992;86:572-578.
47. Hachinski V, Graffagnino C, Beaudry M, Bernier G, Buck C, Donner A, Spence JD, Doig G, Wolfe BM: Lipids and stroke: A paradox resolved. Arch Neurol 1996;53:303-308.
48. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H: Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996;37:2569-2585.